Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya von Aricha, S A, Kingwara, L, Mwirigi, N W, Chaba, L, Kiptai, T, Wahogo, J, Otwabe, J S, Onyango, P O, Karanja, M, Ayieko, C, Matu, S W

Volltext

Cost of TB services in healthcare facilities in Kenya (No 3) von Kairu, A., Orangi, S., Oyando, R., Kabia, E., Nguhiu, P., Ong´ang´o, J., Mwirigi, N., Laurence, Y. V., Kitson, N., Garcia Baena, I., Vassall, A., Barasa, E., Sweeney, S., Cunnama, L.

Volltext

Cost of TB services in healthcare facilities in Kenya (No 3) von Kairu, A, Orangi, S, Oyando, R, Kabia, E, Nguhiu, P, Ong Ang O, J, Mwirigi, N, Laurence, YV, Kitson, N, Garcia Baena, I, Vassall, A, Barasa, E, Sweeney, S, Cunnama, L

Volltext

The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain von Hassler, Shayne N., Kume, Moeno, Mwirigi, Juliet M., Ahmad, Ayesha, Shiers, Stephanie, Wangzhou, Andi, Ray, Pradipta R., Belugin, Serge N., Naik, Dhananjay K., Burton, Michael D., Vagner, Josef, Boitano, Scott, Akopian, Armen N., Dussor, Gregory, Price, Theodore J.

Volltext

The value of diagnostic imaging for enhancing primary care in low- and middle-income countries von Nafade, Vaidehi, Sen, Paulami, Arentz, Matthew, Kadam, Rigveda, Bigio, Jacob, Allen, Luke N., Blandina, Dian Maria, Bosire, Stellah, Ferreira, Julia, Jha, Saurabh, John, Oommen, Kalantri, S.P., Mwirigi, Nkirote, Faal-Omisore, Mamsallah, Ugarte-Gil, Cesar, Vijayan, Shibu, Wangari, Marie-Claire, Pai, Madhukar

Volltext

A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist von Mwirigi, Juliet, Kume, Moeno, Hassler, Shayne N., Ahmad, Ayesha, Ray, Pradipta R., Jiang, Changyu, Chamessian, Alexander, Mseeh, Nakleh, Ludwig, Breya P., Rivera, Benjamin D., Nieman, Marvin T., Van de Ven, Thomas, Ji, Ru-Rong, Dussor, Gregory, Boitano, Scott, Vagner, Josef, Price, Theodore J.

Volltext

Combination therapy with ruxolitinib plus 5‐azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast‐phase myeloproliferative neoplasms von Mwirigi, Anne, Galli, Sofia, Keohane, Clodagh, Raj, Kavita, Radia, Deepti H., Harrison, Claire N., McLornan, Donal P.

Volltext

The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain von Hassler, Shayne N., Kume, Moeno, Mwirigi, Juliet, Ahmad, Ayesha, Shiers, Stephanie, Wangzhou, Andi, Ray, Pradipta, Belugin, Sergei N., Naik, Dhananjay K., Burton, Michael D., Vagner, Josef, Boitano, Scott, Akopian, Armen N., Dussor, Gregory, Price, Theodore J.

Volltext